BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/8/2020 9:25:16 AM | Browse: 816 | Download: 1352
 |
Received |
|
2019-11-12 02:06 |
|
Peer-Review Started |
|
2019-11-12 02:07 |
|
To Make the First Decision |
|
2020-01-07 09:35 |
|
Return for Revision |
|
2020-01-07 09:36 |
|
Revised |
|
2020-03-04 04:32 |
|
Second Decision |
|
2020-03-12 14:14 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-03-12 23:12 |
|
Articles in Press |
|
2020-03-12 23:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-08 02:46 |
|
Publish the Manuscript Online |
|
2020-04-08 09:25 |
| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Outcomes of a drug shortage requiring switching in patients with ulcerative colitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Daniel R van Langenberg, Richard Kai-Yuan Cheng and Mayur Garg |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Daniel R van Langenberg, FRACP, MBBS, PhD, Associate Professor, Department of Gastroenterology, Eastern Health, 8 Arnold Street，Box Hill, Victoria 3128, Australia. daniel.van-langenberg@monash.edu |
| Key Words |
Inflammatory bowel disease; Ulcerative colitis; Drug supply; Drug shortage; Patient outcomes; Market share |
| Core Tip |
As a chronic disease, this study of a drug shortage in ulcerative colitis provides an excellent, novel insight into the short and long term effects of an sudden, unexpected nationwide drug shortage (in this case balsalazide) in patients previously in stable remission. The study highlights the importance of maintaining a seamless drug supply for both patients (given significant rates of disease worsening occurred, directly attributable to shortage), and drug manufacturers given the loss of market share engendered by even a short term drug shortage. |
| Publish Date |
2020-04-08 09:25 |
| Citation |
Langenberg DR, Cheng RKY, Garg M. Outcomes of a drug shortage requiring switching in patients with ulcerative colitis. World J Gastrointest Pathophysiol 2020; 11(2): 32-42 |
| URL |
https://www.wjgnet.com/2150-5330/full/v11/i2/32.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v11.i2.32 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
